✦ LIBER ✦

Analogue-Based Drug Discovery II (FISCHER:DRUG ANALOGS II O-BK) || Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type 2 Diabetes

✍ Scribed by Fischer, János; Ganellin, C. Robin

Book ID: 120001826
Publisher: Wiley-VCH Verlag GmbH & Co. KGaA
Year: 2010
Weight: 257 KB
Category: Article
ISBN: 3527325492
DOI: 10.1002/9783527630035.ch5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dipeptidyl peptidase IV (DPP IV) inhibit

Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes.

✍ Green, Brian D; Flatt, Peter R; Bailey, Clifford J 📂 Article 📅 2006 🏛 International Society of Diabetes and Vascular Dis 🌐 English ⚖ 120 KB

A triumph for physiology driving drug di

A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetes

✍ Richard Donnelly 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

[Methods and Principles in Medicinal Che

[Methods and Principles in Medicinal Chemistry] Antitargets || Selective Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type 2 Diabetes: The Discovery of JANUVIA(™) (Sitagliptin)

✍ Vaz, Roy J.; Klabunde, Thomas 📂 Article 📅 2008 🏛 Wiley 🌐 German ⚖ 824 KB

addressing A Common Challenge That Is Faced By Every Drug Developer, This Practice-oriented Handbook Surveys Current Knowledge On The Occurrence And Prevention Of Adverse Drug Reactions Related To Off-target Activity Of Small Molecule Drugs. it Is Unique In Collating The Current Approaches Into A S